Six Months In, AZA Law Firm’s Dallas Office Tracks Toward Its Year-One Plan
By Exec Edge Editorial Staff AZA Law Firm opened its Dallas office at the Trammell...
Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM
By Karen Roman Glucotrack, Inc. (Nasdaq: GCTK) said the US Patent and Trademark Office issued...
The Cancer Therapy Strategy VERAXA Is Betting the Company On
By Karen Roman VERAXA Biotech AG (Nasdaq: VRXA) said it expects BiTAC molecules to be...
CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology
By Karen Roman CareDx, Inc. (Nasdaq: CDNA) said it completed the acquisition of Naveris, which...
VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone
By Karen Roman VERAXA Biotech AG (Nasdaq: VRXA) said it started cell line development for...
SkylineDx’s Merlin CP-GEP Granted FDA Breakthrough Device Designation
By Karen Roman SkylineDx said the FDA granted Breakthrough Device Designation to Merlin CP-GEP, the...
Imviva Biotech Granted FDA IDE Authorization for Cancer Treatment Trial
By Karen Roman Imviva Biotech said it has FDA authorization for its Investigational Device Exemption...
Tackling the AI Security Crisis: Pax8’s Rob Belgrave and SentinelOne’s Steve Stone, Live from Pax8 Beyond 2026
Tech Edge hosted a fireside chat on June 9 at Pax8 Beyond 2026 in Salt...
Human-led Management of Autonomous Digital Workers: Pax8 Global Sr Director Renee McCloden, Halo CCO Tim Barton-Wines, Live from Pax8 Beyond 2026
Watch Video Highlights Below, or Click HERE: Tech Edge hosted a fireside chat on June...
The AI Race Has Changed: How MSPs Drive Growth for SMBs: Pax8 CSO Ryan Walsh, possibl.ai CEO Nyssa Waters, Live from Pax8 Beyond 2026
Watch Video Highlights Below, or Click HERE: Tech Edge hosted a fireside chat on June...
© Copyright 2025, ExecEdge